These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4549 related items for PubMed ID: 628002

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Triazene metabolism. III. In vitro cytotoxicity towards M21 cells and in vivo antitumour activity of the proposed metabolites of the antitumour 1-aryl-3,3-dimethyltriazenes.
    Kohlsmith DJ, Vaughan K, Luner SJ.
    Can J Physiol Pharmacol; 1984 Apr; 62(4):396-402. PubMed ID: 6733585
    [Abstract] [Full Text] [Related]

  • 23. Potential antitumor agents. 56. "Minimal" DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides.
    Atwell GJ, Bos CD, Baguley BC, Denny WA.
    J Med Chem; 1988 May; 31(5):1048-52. PubMed ID: 3361574
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.
    MacDiarmid JE, Rose WC, Biddle WC, Perlman ME, Breiner RG, Ambrus JL, Bardos TJ.
    J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Synthesis, antileukemic activity, and stability of 3-(substituted-triazeno)pyrazole-4-carboxylic acid esters and 3-(substituted-triazeno)pyrazole-4-carboxamides.
    Shealy YF, O'Dell CA.
    J Pharm Sci; 1971 Apr; 60(4):554-60. PubMed ID: 5128363
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S, Wang Y, Inoue K, Ogawa M.
    Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
    [Abstract] [Full Text] [Related]

  • 37. Cell kinetics and immunoegenicity of lymphoma cells treated with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DIC) in vivo.
    Silvestrini R, Testorelli C, Goldin A, Nicolin A.
    Int J Cancer; 1977 May 15; 19(5):664-9. PubMed ID: 863544
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
    Roehrig GR, Billman JH, Marcec J, Fritz P, Shea F.
    J Pharm Sci; 1980 Oct 15; 69(10):1232-4. PubMed ID: 7420301
    [Abstract] [Full Text] [Related]

  • 39. Some short-chain N6-substituted adenosine analogues with antitumor properties.
    Fleysher MH, Bernacki RJ, Bullard GA.
    J Med Chem; 1980 Dec 15; 23(12):1448-52. PubMed ID: 7452700
    [Abstract] [Full Text] [Related]

  • 40. Potential antitumor agents. 51. Synthesis and antitumor activity of substituted phenazine-1-carboxamides.
    Rewcastle GW, Denny WA, Baguley BC.
    J Med Chem; 1987 May 15; 30(5):843-51. PubMed ID: 3572972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 228.